# An Observational Study Evaluating the Safety, Tolerability, and Efficacy of Treatment of SM04690 or Placebo Previously Injected in the Target Knee Joint of Subjects With Moderately to Severely Symptomatic Osteoarthritis

> **NCT02951026** · — · COMPLETED · sponsor: **Biosplice Therapeutics, Inc.** · enrollment: 703 (actual)

## Conditions studied

- Osteoarthritis

## Interventions

- **OTHER:** Not applicable (no therapy is administered as part of this study)

## Key facts

- **NCT ID:** NCT02951026
- **Lead sponsor:** Biosplice Therapeutics, Inc.
- **Sponsor class:** INDUSTRY
- **Phase:** —
- **Study type:** OBSERVATIONAL
- **Status:** COMPLETED
- **Start date:** 2016-09-19
- **Primary completion:** 2019-10-31
- **Final completion:** 2019-10-31
- **Target enrollment:** 703 (ACTUAL)
- **Last updated:** 2020-04-17


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT02951026

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT02951026, "An Observational Study Evaluating the Safety, Tolerability, and Efficacy of Treatment of SM04690 or Placebo Previously Injected in the Target Knee Joint of Subjects With Moderately to Severely Symptomatic Osteoarthritis". Retrieved via AI Analytics 2026-06-26 from https://api.ai-analytics.org/clinical/NCT02951026. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*